alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2020103EN.01002501.xml

| 30.3.2020 | EN | Official Journal of the European Union | C 103/25 |
| --- | --- | --- | --- |

30.3.2020

EN

Official Journal of the European Union

C 103/25

---

Judgment of the General Court of 12 February 2020 — Ramazani Shadary v Council

(Case T-173/18) (1)

(Common foreign and security policy - Restrictive measures taken in view of the situation in the Democratic Republic of the Congo - Freezing of funds - Renewal of the listing of the applicant’s name on the list of persons concerned - Obligation to state reasons - Rights of the defence - Obligation for the Council to communicate the new elements justifying the renewal of the restrictive measures - Error of law - Manifest error of assessment - Right to property - Proportionality - Presumption of innocence - Plea of illegality)

(2020/C 103/34)

Language of the case: French

Parties

Applicant: Emmanuel Ramazani Shadary (Kinshasa, Democratic Republic of the Congo) (represented by: T. Bontinck, P. De Wolf, M. Forgeois and A. Guillerme, lawyers)

Defendant: Council of the European Union (represented by: J.-P. Hix, S. Lejeune and H. Marcos Fraile, acting as Agents)

Re:

Application based on Article 263 TFEU seeking annulment of Council Decision (CFSP) 2017/2282 of 11 December 2017 amending Decision 2010/788/CFSP concerning restrictive measures against the Democratic Republic of the Congo (OJ 2017 L 328, p. 19), in so far as it concerns the applicant.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Mr Emmanuel Ramazani Shadary to pay the costs. |
| --- | --- |

2.

Orders Mr Emmanuel Ramazani Shadary to pay the costs.

---

(1)  OJ C 161, 7.5.2018.

---
Exhibit 32.1

                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 In connection with  the Annual Report  of American  HealthChoice, Inc.  (the
 "Company")  on  Form 10-KSB/A  for  the period ending September 30, 2005  as
 filed with the Securities  and  Exchange Commission on the date hereof  (the
 "Report"), I  Dr. J.  W. Stucki,  Chief Executive  Officer of  the  Company,
 certify, pursuant to 18 U.S.C. S 1350, as  adopted pursuant to S 906 of  the
 Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

      (1)  The Report fully complies with  the requirements of Section  13(a)
           or 15(d) of the Securities Exchange Act of 1934; and

      (2)  The information contained  in the Report  fairly presents, in  all
           material  respects,  the   financial  condition   and  result   of
           operations of the Company.


 /s/ Dr. J. W. Stucki

 Dr. J. W. Stucki
 Chief Executive Officer
 July 14, 2006
### SAT Report PMN Number: P-14-0110 SAT Date: 12/6/2013 Print Date: 7/2/2014

Related cases :

Concern levels : Type of Concern: Health Eco Comments Level of Concern: 1-2 3

Persistence Bioaccum Toxicity Comments 3 11

Exposure Based Review : Health: N o Ecotox: Yes Exposure based testing (eco): Fish ELS Toxicity Test (OCSPP 850.1400); Sediment-Water Chironomid Life-Cycle Toxicity Test Using Spiked Sediment (OECD TG 233)); Algae Toxicity Test (OCSPP 850.4500)
Routes of exposure : Health: Dermal Inhalation Ecotox: All releases to water Fate: ; Keywords : Keywords: IRR-E,S,MM,L; SENS-S; AQUATOX
Summary of Assessment :

Fate : Fate Summary: P-14-0110 FATE: Liquid with MP < 25 C (E) S = 21.4 mg/L at 25 °C (EPI for n=1) VP < 1.0E-6 torr at 25 C (E) BP > 400 C (E) H < 1.00E-8 (E)POTW removal (%) = 90 via sorption Time for complete ultimate aerobic biodeg > mo Sorption to soils/sediments = v.strong PBT Potential: P3B1 *CEB FATE: Migration to ground water = negl

Health : Health Summary: Absorption of low molecular weight fractions is expected to be poor all routes ( p che m ). Concern for irritation to all tissues based on the submitted skin irritation study, and dermal sensitization based on the cashew nutshell component. Test Data: rat oral LD0 = 2000 mg/kg; some skin irritation in rabbits

Ecotox :
Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 0.273 daphnid 48-h LC50 0.368 green algal 96-h EC50 0.045 fish

_ chronic value 0.012 daphnid

_ chronic value 0.014

algal

_ chronic value 0.02
Sewage Sludge 3-h EC50

_ Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for SAR chemical class = log Kow = 5.4 (EPI, n=1); liquid with mp unknown (P); S = 0.21 mg/L at 20 C (P); p H7; effective concentrations based on 100% active ingredients and mean measured concentrations; hardness <150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern ( p pb) 1

SARs SAR Class Ecotox Category

Ecotox Factors Comments:SAT Chair: L Keifer 564-8916
# C_2019044EN.01007501.xml

| 4.2.2019 | EN | Official Journal of the European Union | C 44/75 |
| --- | --- | --- | --- |

4.2.2019

EN

Official Journal of the European Union

C 44/75

---

Order of the President of the General Court of 25 October 2018 — ZD v Parliament

(Case T-591/18 R)

((Application for interim measures - Civil service - Officials - Suspension of an official from duties without withholding remuneration - Application for suspension of operation of a measure - Damage to reputation - No urgency))

(2019/C 44/99)

Language of the case: French

Parties

Applicant: ZD (represented by: S. Pappas, lawyer)

Defendant: European Parliament (represented by: J. Steele and V. Montebello-Demogeot, Agents)

Re:

Application under Articles 278 and 279 TFEU for suspension of operation of the decision of the Secretary General of the Parliament of 25 September 2018 suspending the applicant from duties for a fixed period without withholding remuneration.

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The costs are reserved. |
| --- | --- |

2.

The costs are reserved.

---
# Doses Distributed

# Instructions
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 67 Introduced in House (IH)]

114th CONGRESS
  1st Session
H. RES. 67

 Expressing support for designation of February 12, 2015, as ``Darwin 
 Day'' and recognizing the importance of science in the betterment of 
                               humanity.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 2, 2015

    Mr. Himes (for himself, Mr. Schiff, Mr. Pocan, Ms. DeLauro, Ms. 
 Slaughter, Mr. Honda, Mr. Cohen, Mr. Foster, Ms. Lofgren, Ms. Norton, 
 Mr. Cartwright, and Mr. Smith of Washington) submitted the following 
resolution; which was referred to the Committee on Science, Space, and 
                               Technology

_______________________________________________________________________

                               RESOLUTION

 
 Expressing support for designation of February 12, 2015, as ``Darwin 
 Day'' and recognizing the importance of science in the betterment of 
                               humanity.

Whereas Charles Darwin's theory of evolution by the mechanism of natural 
        selection, together with the monumental amount of scientific evidence he 
        compiled to support it, provides humanity with a logical and 
        intellectually compelling explanation for the diversity of life on 
        Earth;
Whereas the validity of Darwin's theory of evolution by natural selection is 
        further strongly supported by the modern understanding of the science of 
        genetics;
Whereas it has been the human curiosity and ingenuity exemplified by Darwin that 
        has promoted new scientific discoveries that have helped humanity solve 
        many problems and improve living conditions;
Whereas the advancement of science must be protected from those unconcerned with 
        the adverse impacts of global warming and climate change;
Whereas the teaching of creationism in some public schools compromises the 
        scientific and academic integrity of the United States education 
        systems;
Whereas Charles Darwin is a worthy symbol of scientific advancement on which to 
        focus and around which to build a global celebration of science and 
        humanity intended to promote a common bond among all of Earth's peoples; 
        and
Whereas February 12, 2015, is the anniversary of the birth of Charles Darwin in 
        1809 and would be an appropriate date to designate as ``Darwin Day'': 
        Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the designation of ``Darwin Day''; and
            (2) recognizes Charles Darwin as a worthy symbol on which 
        to celebrate the achievements of reason, science, and the 
        advancement of human knowledge.
                                 <all>
```
An Equal Opportunity Provider and Employer

CENTER FOR VETERINARY BIOLOGICS NOTICE 18-03

TO: Veterinary Services Leadership Team 

Directors, Center for Veterinary Biologics 

Biologics Licensees, Permittees, and Applicants

FROM: Byron E. Rippke

Director

SUBJECT: Changes in True Names Based on Accepted Nomenclature

I. PURPOSE

The Center for Veterinary Biologics (CVB) recognizes that names of organisms 

may change over time due to taxonomic investigations and subsequent 

reclassification. The CVB uses this Notice to inform firms of the CVB process for 

approving changes in product True Names.

II. POLICY

The CVB will consider requests for changes in product True Names based on 

acceptance of the new nomenclature by the appropriate organization(s) and by the 

scientific community over a reasonable period of time (e.g., usage via publication in 

applicable, reputable journals). In the submission, the firm should include such 

justification. Regarding appropriate organizations, for bacterial agents, see the List 

of Prokaryotic Names with Standing in Nomenclature site:

http://www.bacterio.net/index.html. The International Committee on Taxonomy of 

Viruses site provides official names of viruses: 

http://www.ictvonline.org/virusTaxonomy.asp. For animal parasites, see the 

International Commission on Zoological Nomenclature site: 

http://iczn.org/content/about-zoobank. For other organisms, regarding evidence of 

acceptance of the new nomenclature by pertinent organizations and the scientific 

community, the firm should submit relevant publications and/or a list of references. 

The CVB may also initiate the True Name change as deemed necessary. 

Upon CVB approval, the CVB issues a Notice informing all firms of the change in 

the True Name. The CVB will use the new nomenclature for products in prelicense

stage. For licensed products, the CVB requires revision of the Outlines of 

Production and labels. All affected firms must comply within within 2 years. The

firm may opt to use both genus names, e.g., Avibacterium (Haemophilus) 

paragallinarum, on labels for up to 2 years. 

The CVB will issue a new license within 60 days of approval of the new True 

Name, as documented by issuance of the Notice. It is not necessary for the firm to 

make a submission to request issuance of a new license with an updated True 

Name.

Animal and Plant

Health Inspection

Service

Veterinary Services

Center for Veterinary 

Biologics

1920 Dayton Avenue

PO Box 844

Ames, IA 50010

(515) 337-6100
Firms seeking detailed guidance may contact CVB-Policy, Evaluation, and Licensing or 

their assigned Reviewer.

III. IMPLEMENTATION/ APPLICABILITY

Implementation is effective immediately.
#### IN RE: Barry Charles DOCKERY, Movant

No. 17-50367

United States Court of Appeals, Fifth Circuit.

FILED July 20, 2017

Barry Charles Dockery, Pro se.

Before JOLLY, HAYNES, and GRAVES, Circuit Judges.

PER CURIAM:

Barry Charles Dockery, federal prisoner # 57922-180, moves for authorization to file a successive 28 U.S.C. § 2255 motion to challenge his convictions and sentences for possession of a firearm by a felon, unlawful possession of an unregistered firearm, possession of a firearm in furtherance of a drug trafficking crime, conspiracy to distribute and possess with intent to distribute marijuana and cocaine base, possession of cocaine base with intent to distribute, and possession of marijuana with intent to distribute. He seeks authorization in light of *Dean v. United States,*_ U.S. _, 137 S.Ct. 1170, 197 L.Ed.2d 490 (2017).

To obtain authorization, a movant must make a prima facie showing that his proposed claims rely on either “newly discovered evidence that, if proven and viewed in light of the evidence as a whole, would be sufficient to establish by clear and convincing evidence that no reasonable factfinder would have found the movant guilty of the offense” or “a new rule of constitutional law, made retroactive to cases on collateral review by the Supreme Court, that was previously unavailable.” § 2255(h); *see also*28 U.S.C. § 2244(b)(3)(C); *Reyes-Requena v. United States,*243 F.3d 893, 897-99 (5th Cir. 2001).

.Dockery does not assert that his claims rely on newly discovered evidence, nor has he made a prima facie showing that *Dean*announced a new rule of constitutional law that was made retroactive to cases on collateral review by the Supreme Court. *See*§ 2255(h)(2); *In re*Tatum, 233 F.3d 857, 859 (5th Cir. 2000). Accordingly, IT IS ORDERED that Dockery’s motion for authorization to file a successive § 2255 motion is DENIED.
CSB BANCORP, INC.EXHIBIT 32.1SECTION 1350 CERTIFICATIONIn connection with the quarterly report of CSB Bancorp, Inc. (the “Company”) on Form 10-Q for thesix-month period ended June 30, 2005 as filed with the Securities and Exchange Commission on thedate hereof (the “Report”), I, John J. Limbert, President and Chief Executive Officer, certify,pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.   /s/ John J. Limbert     John J. Limbert  President and Chief Executive Officer   *   This certification is being furnished as required by Rule 13a-14(b) under the Securities ExchangeAct of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United StatesCode, and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwisesubject to the liability of that section. This certification shall not be deemed to be incorporatedby reference into any filing under the Securities Act of 1933 or the Exchange Act, except asotherwise stated in such filing.
23.
The Animal and Plant Health Inspection Service (APHIS) will hold five virtual listening sessions 

to receive public input on topics related to updates and improvements to the Chronic Wasting 

Disease (CWD) Herd Certification Program Standards. Section 603 of the Fiscal Year 2023 

Omnibus Appropriations Bill enacted the Chronic Wasting Disease Research and Management 

Act (H.R. 5608, the CWD Research and Management Act). Under the terms of the CWD 

Research and Management Act, APHIS must “solicit public feedback on potential updates and 

improvements” to the Chronic Wasting Disease Herd Certification Program Standards. Pursuant 

to the CWD Research and Management Act, APHIS is publishing this notice soliciting public 

feedback on potential updates and improvements to the CWD Program Standards. Specifically, 

we are scheduling a series of virtual listening sessions to gather information that will help us in 

evaluating and potentially amending the Program Standards consistent with the CWD Research 

and Management Act. The deadline to register to speak at the second listening session is August

3, 2023, and one week prior to subsequent listening sessions. You may provide written comments 

at the meetings by using the meeting chat function or file written comments before, during, or 

after the meetings by emailing CWD@usda.gov or mailing to Dr. Hillary A. McManama, 

Veterinary Medical Officer, Cervid Health Staff, Strategy and Policy, Veterinary Services, 

APHIS; c/o Ms. Melanie Rouse, 4700 River Road Unit 43, Riverdale, MD 20737. Written 

comments by attendees or other interested stakeholders will be welcomed for the public record 

up to close of business on Monday, November 13, 2023. Please refer to Docket No. APHIS2023-0042 when submitting your comments.

Meeting topics for Listening Session #2:

• Identification, inspection and inventory, including: 

o animal identification (ID) requirements

o electronic ID (EID)

o annual and physical herd inspection procedures

Specific questions we are seeking input on:

• Should electronic ID (EID) be required and if so, should EID implants be required?

Instructions and expectations for speakers during the call:

-The listening session will be recorded.

-You must have indicated on the registration form that you wish to speak during the 

listening session. A predetermined order will be followed for those that indicated they 

wish to speak during the session. The facilitator will call on you when it is your turn to 

speak.

-Please introduce yourself by name and affiliation at the start of your comments.

-Comments will be limited to a maximum of 3 to 5 minutes depending on the number of 

requests to speak. The facilitator will let you know before the call how long the 

comments can be and let you know when you have 30 seconds left.

-Keep the discussion focused on the meeting topics and be respectful.

-Focus on interests, not on positions.

-Be specific—Use examples.

-Refrain from using profanity or distracting the group.
#### State v. Perry

21517

02/10/1999

Vacated and Remanded
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 735 Engrossed in House (EH)]

<DOC>
H. Res. 735

                In the House of Representatives, U. S.,

                                                          May 18, 2016.
    Resolved, That at any time after adoption of this resolution the Speaker 
may, pursuant to clause 2(b) of rule XVIII, declare the House resolved into the 
Committee of the Whole House on the state of the Union for further consideration 
of the bill (H.R. 4909) to authorize appropriations for fiscal year 2017 for 
military activities of the Department of Defense and for military construction, 
to prescribe military personnel strengths for such fiscal year, and for other 
purposes.
    Sec. 2.  (a) No further amendment to the bill, as amended, shall be in order 
except those printed in the report of the Committee on Rules accompanying this 
resolution and amendments en bloc described in section 3 of this resolution.
     (b) Each further amendment printed in the report of the Committee on Rules 
shall be considered only in the order printed in the report, may be offered only 
by a Member designated in the report, shall be considered as read, shall be 
debatable for the time specified in the report equally divided and controlled by 
the proponent and an opponent, shall not be subject to amendment, and shall not 
be subject to a demand for division of the question in the House or in the 
Committee of the Whole.
    (c) All points of order against the further amendments printed in the report 
of the Committee on Rules or amendments en bloc described in section 3 of this 
resolution are waived.
    Sec. 3.  It shall be in order at any time for the chair of the Committee on 
Armed Services or his designee to offer amendments en bloc consisting of 
amendments printed in the report of the Committee on Rules accompanying this 
resolution not earlier disposed of. Amendments en bloc offered pursuant to this 
section shall be considered as read, shall be debatable for 20 minutes equally 
divided and controlled by the chair and ranking minority member of the Committee 
on Armed Services or their designees, shall not be subject to amendment, and 
shall not be subject to a demand for division of the question in the House or in 
the Committee of the Whole.
    Sec. 4.  At the conclusion of consideration of the bill for amendment 
pursuant to this resolution the Committee shall rise and report the bill to the 
House with such further amendments as may have been adopted. The previous 
question shall be considered as ordered on the bill and amendments thereto to 
final passage without intervening motion except one motion to recommit with or 
without instructions.
            Attest:

                                                                          Clerk.
```
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL STATEMENTS INFORMATION EXTRACTED FROM
JUNE 30, 1999 10-QSB AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                      10,773,729
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                             4,330,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 65,890,378
<INVESTMENTS-CARRYING>                       5,360,105
<INVESTMENTS-MARKET>                         5,286,109
<LOANS>                                    224,704,095
<ALLOWANCE>                                  2,954,857
<TOTAL-ASSETS>                             323,485,450
<DEPOSITS>                                 265,002,224
<SHORT-TERM>                                17,078,071
<LIABILITIES-OTHER>                          2,767,271
<LONG-TERM>                                  9,000,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,280,269
<OTHER-SE>                                  23,357,616
<TOTAL-LIABILITIES-AND-EQUITY>              29,637,884
<INTEREST-LOAN>                              9,589,052
<INTEREST-INVEST>                            1,805,213
<INTEREST-OTHER>                               151,332
<INTEREST-TOTAL>                            11,545,597
<INTEREST-DEPOSIT>                           4,686,581
<INTEREST-EXPENSE>                           5,129,254
<INTEREST-INCOME-NET>                        6,416,343
<LOAN-LOSSES>                                  424,000
<SECURITIES-GAINS>                              (1,128)
<EXPENSE-OTHER>                              5,222,893
<INCOME-PRETAX>                              2,634,517
<INCOME-PRE-EXTRAORDINARY>                   2,634,517
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,668,466
<EPS-BASIC>                                       0.80
<EPS-DILUTED>                                     0.80
<YIELD-ACTUAL>                                       0
<LOANS-NON>                                  2,340,000
<LOANS-PAST>                                    43,000
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                             2,714,639
<CHARGE-OFFS>                                  221,582
<RECOVERIES>                                    37,800
<ALLOWANCE-CLOSE>                            2,954,857
<ALLOWANCE-DOMESTIC>                         2,954,857
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
September 1, 2000

22602

#### Doe, In re

Affirmed